NCT00472316

Brief Summary

This study is designed as a cluster-randomized trial. The cluster unit is at the community level. Communities will be randomized to 1 of 2 study arms: DOTS+ACF or DOTS. Communities in the DOTS+ACF arm will receive door-to-door symptom screening of the entire population by health care workers between 2 and 4 times over a 9-month period. Those communities in the DOTS-arm will receive the current standard of care in those communities (PCF). All study communities will be receiving between 4 and 6 visits by community health workers annually as part of a program to assess and follow-up illnesses in each household. Households with ill residents will be visited more often. The intervention for this study is simply adding 3 to 5 simple questions to the current protocol. For subjects responding positively to these questions, results will be returned to the subject at their home and routine, standard of care follow-up diagnostic and treatment algorithms will be followed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 11, 2007

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

August 18, 2017

Status Verified

August 1, 2017

Enrollment Period

2.4 years

First QC Date

May 10, 2007

Last Update Submit

August 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare TB incidence in communities randomized to DOTS+ACF and DOTS alone over the 18-month period following ACF campaign.

    18 months following invetervention

Secondary Outcomes (1)

  • To compare case notification rates of TB in the 2 arms of the study during the ACF campaign.

    During the intervention

Interventions

Active case finding of TB in the community using community health workers

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Residents of AP3.1 and AP 5.3 in Rio de Janeiro Brazil

You may qualify if:

  • All residents of the study communities will be eligible to be surveyed at their homes, regardless of gender, age, or ethnicity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Health Department of Rio de Janeiro, Brazil

Rio de Janeiro, Brazil

Location

MeSH Terms

Conditions

Tuberculosis

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

  • Jonathan Golub, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2007

First Posted

May 11, 2007

Study Start

May 1, 2007

Primary Completion

October 1, 2009

Study Completion

May 1, 2011

Last Updated

August 18, 2017

Record last verified: 2017-08

Locations